Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)

Journal of Geriatric Oncology

Volumn 6, Issue 4, 2015, Pages 272-279

  Luciani, Andrea ^a   Biganzoli, Laura ^b   Colloca, Giuseppe ^c   Falci, Cristina ^d   Castagneto, Bruno ^e   Floriani, Irene ^f   Battisti, Nicolò ^a   Dottorini, Lorenzo ^a   Ferrari, Daris ^a   Fiduccia, Pasquale ^d   Zafarana, Elena ^b   Del Monte, Francesca ^b   Galli, Francesca ^f   Monfardini, Silvio ^g   Foa, Paolo ^a  

^a SAN PAOLO HOSPITAL   (Italy)

^b Hospital of Prato   (Italy)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^d Istituto Oncologico   (Italy)

^e Department of Oncology San Giacomo Hospital ^*  (Italy)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^g IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Chemotherapy; Older; Toxicity; VES 13

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; CUMULATIVE ILLNESS RATING SCALE FOR GERIATRICS SCORE; DRUG DOSE REDUCTION; FATIGUE; FEMALE; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEOPLASM; NEUTROPENIA; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; VULNERABLE ELDERS SURVEY 13; GERIATRIC ASSESSMENT; NEOPLASMS; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; GERIATRIC ASSESSMENT; HEALTH SURVEYS; HUMANS; MALE; NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84938996361     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.02.005     Document Type: Article

References (32)

1. National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. J Am Geriatr Soc 1988, 36:342-347.
2. Rubenstein L.Z., Josephson K.R., Wieland G.D., et al. Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med 1984, 311:1664-1670.
3. Monfardini S., Ferrucci L., Fratino L., et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996, 77:395-401.
4. Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20:494-502.
5. Luciani AJ P.B., Extermann M., Foa P., Marussi D., Ferrari D., Morabito A., et al. The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy. J Geriatr Oncol 2012, 3.
6. Extermann M., Boler I., Reich R.R., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012, 118:3377-3386.
7. Falandry C., Brain E., Bonnefoy M., et al. Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trial. Eur J Cancer 2013, 49:2806-2814.
8. Hurria A., Togawa K., Mohile S.G., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011, 29:3457-3465.
9. Balducci L., Colloca G., Cesari M., Gambassi G. Assessment and treatment of elderly patients with cancer. Surg Oncol 2010, 19:117-123.
10. Molina-Garrido M.J., Guillen-Ponce C. Comparison of two frailty screening tools in older women with early breast cancer. Crit Rev Oncol Hematol 2011, 79:51-64.
11. Owusu C., Koroukian S.M., Schluchter M., et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol 2011, 2:121-129.
12. Luciani A., Ascione G., Bertuzzi C., et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010, 28:2046-2050.
13. Mohile S.G., Bylow K., Dale W., et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007, 109:802-810.
14. Biganzoli L., Boni L., Becheri D., et al. Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?. Ann Oncol 2013, 24:494-500.
15. Pottel L.B.T., Pottel H., Goethals L., Van Den Noortgate N., Duprez F., De Neve W., et al. Determination of an adequate screening tool for the identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy. J Geriatr Oncol 2012, 3:24-32.
16. Min L.C., Elliott M.N., Wenger N.S., Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 2006, 54:507-511.
17. Saliba D., Elliott M., Rubenstein L.Z., et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001, 49:1691-1699.
18. Castagneto B., Di Pietrantonj C., Stevani I., et al. The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer. Med Oncol 2013, 30:708.
19. Falci C.B.U., Fiduccia P., Brunello A., Baretta Z., Solda C., Lamberti E., et al. Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)?. Crit Rev Oncol Hematol 2009, 72(Suppl. 1):S19-S20.
20. Miller M.D., Paradis C.F., Houck P.R., et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992, 41:237-248.
21. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
22. Gerber V., Krieg M.A., Cornuz J., et al. Nutritional status using the Mini Nutritional Assessment questionnaire and its relationship with bone quality in a population of institutionalized elderly women. J Nutr Health Aging 2003, 7:140-145.
23. Barone L., Milosavljevic M., Gazibarich B. Assessing the older person: is the MNA a more appropriate nutritional assessment tool than the SGA?. J Nutr Health Aging 2003, 7:13-17.
24. Bleda M.J., Bolibar I., Pares R., Salva A. Reliability of the mini nutritional assessment (MNA) in institutionalized elderly people. J Nutr Health Aging 2002, 6:134-137.
25. Janssen-Heijnen M.L., Extermann M., Boler I.E. Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?. Crit Rev Oncol Hematol 2011, 79:43-50.
26. Extermann M., Bonetti M., Sledge G.W., et al. MAX2-a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 2004, 40:1193-1198.
27. Extermann M., Chen H., Cantor A.B., et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002, 38:1466-1473.
28. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25:1824-1831.
29. Stokoe JM P.J., SinhaR Ring A. G8 and VES-13 scores predict chemotherapy toxicity in older patients with cancer. J Geriatr Oncol 2012, 3:S81.
30. Decoster L., Van Puyvelde K., Mohile S., et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger. Ann Oncol 2014, 26(2):288-300.
31. Rodin M.B., Mohile S.G. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007, 25:1936-1944.
32. Hurria A. Management of elderly patients with cancer. J Natl Compr Canc Netw 2013, 11:698-701.